We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Plant Health Care Plc | LSE:PHC | London | Ordinary Share | GB00B01JC540 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.01 | 0.26% | 3.82 | 3.70 | 3.94 | - | 78,099 | 16:35:18 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pesticides, Agric Chems, Nec | 11.77M | -9.48M | -0.0278 | -1.37 | 13.01M |
Date | Subject | Author | Discuss |
---|---|---|---|
02/5/2023 13:11 | Is the volume large enough to suggest that? | davemac3 | |
02/5/2023 12:52 | Board already made up their minds. RNS deliberately tanked the share price so TR1 holders aligned with the Board can hoover up, and get the votes to push through their agenda.Now they are pushing the pump button | oapknob1 | |
02/5/2023 11:07 | hxxps://ukinvestorma | callumross | |
02/5/2023 09:14 | That’s possible like Spectral MD who I think are reversing into a SPAC already on Nasdaq but still very expensive to do. | remslie | |
02/5/2023 09:06 | Not sure I completely understand the wobble here. “The board is mindful of the impact to existing shareholders of any potential future equity raise at current share price levels” Says the non-exec chairman, a man who holds more that 1% of the company’s shares, many in an ISA. Seems clear to me they’re trying to improve the status of the company whilst protecting shareholders. ‘If’ a reverse takeover occurs, this would by a quick and less expensive way to list on an exchange. It also increases liquidity (currently lacking for PHC) and increases the share price | pretax2 | |
02/5/2023 08:50 | Means nothing if they delist. No wonder they weren't doing a presentation on InvestorMeet platform for these results. PI's totally shafted | oapknob1 | |
02/5/2023 08:48 | On cash, Cenkos are projecting positive cash balances for this year and slightly more than their previous numbers and an increase in cash at end 2024 and major increase in 2025. | sidam | |
02/5/2023 08:46 | Bailed. Shocking way to treat PI's. No trust in this Board. Shame. Good company with great prospects. Capital better elsewhere.Good luck if still holding. Either be taken private and delist or rto onto US listing.Watching from side now. | oapknob1 | |
02/5/2023 08:42 | If Cenkos are correct, the fall in the share price appears ridiculous. They have reduced 2024 revenues by about 10% and projected a small profit. For 2025 the look for a PER of less than 3 at the current price and have a target of 37p. So, assuming Cenkos are correct and the share price is 9p, the shares will be profitable in the then current year and stand at next year’s PER of 3 when it is projected to still be growing at 30% for the next few years. I think their target is too low, but this could be a superb buying opportunity. The only problem appears to be the “consultation& | sidam | |
02/5/2023 08:35 | My guess is Nasdaq far too expensive, takeover does not crystallise value at this level even at a significant premium so going private with a large trade or private equity fund taking a minority stake the most likely. The alternative is to have another fund raise which would be unwelcome at these prices to fund growth. My sense is that any private option would include an offer to take out the smaller stockholders who did not want to lose liquidity which would be funded by the new shareholder. This might be combined with a convertible bond with a conversion price at a significant premium to avoid the dilution. It depends though on the large shareholders agreeing to go private. I suspect the management are trying to avoid taking on short term debt as the costs and risks would be prohibitive before they are clearly profitable. Who knows but not sure the statement is good for sentiment and would have been better to draft behind close doors prior to this vague announcement. | remslie | |
02/5/2023 08:27 | Possible reverse into a listed US. specialist likely. | geraldus | |
02/5/2023 08:18 | Well that announcement hasn’t helped “the share price performance” | davemac3 | |
02/5/2023 08:08 | Not sure what the options are? Nasdaq, private, takeover? | davemac3 | |
02/5/2023 08:06 | Cenkos upped target price to 37p but no mention of the consultation. | geraldus | |
02/5/2023 07:50 | Some uncertainity in the mix now and possibly won't go down well. | geraldus | |
02/5/2023 07:37 | double post - | pugugly | |
02/5/2023 07:37 | Not so sure - Looks like a possible kick in the "you know what" for the average PI. | pugugly | |
02/5/2023 07:16 | Here we are, patience is a virtue. | geraldus | |
02/5/2023 07:13 | Somebody's slept in stateside. | geraldus | |
02/5/2023 07:08 | Where's these results then ? | oapknob1 | |
29/4/2023 16:07 | PHC is a volatile stock with relatively few shares in issue. So tech analysis leads to you adjusting your trend lines quite a lot. However on the monthly and quarterly charts there is a triangle stretching back 5 years. The bigger the triangle, the bigger the breakout. The fundamentals have manifestly improved (something that’s about to be confirmed by the final results) so we await the market catching up. | pretax2 | |
28/4/2023 20:46 | Maybe if it breaks 13-14 | oapknob1 | |
27/4/2023 12:08 | is this a breakout? | davemac3 | |
26/4/2023 17:48 | If you look at my post of 2 March, you will see that Cenkos are projecting a profit the year we are now in and a realistic PER. So it might be right to buy as I did after my earlier post. | sidam |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions